- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 76
Coral corrals corporates for $45m Japan fund
The 500 Startups Japan team have spun off as Coral Capital and launched a $45m fund backed by Mitsubishi Estate, J-Power, Mizuho Bank and Shinsei Bank.
Mar 7, 2019Vilmorin & Cie passes into PSL fund
Vilmorin & Cie has joined fellow corporates including BNP Paribas, Naval Group, KPN, Famille C and Mgen as an investor in PSL Innovation Fund, which is targeting an $87.5m close.
Mar 6, 2019Ravina rises at Engie EPS
Engie New Ventures alumnus Giovanni Ravina, became chief innovation officer for another Engie subsidiary, Engie EPS, in January this year.
Mar 5, 2019BFG meets corporates for giant $100m fund
The venture capital firm has sourced commitments from investors including Arlon Group and Rabobank for a $100m food and beverage-focused fund known as BFG Fund II.
Mar 4, 2019Folau joins LMI Ventures
Ian Folau, a co-founder and former CEO of GitLinks, has been hired by the recently launched LMI Ventures as a managing director.
Feb 26, 2019Mubadala mobilises SoftBank in $400m fund
SoftBank has reportedly invested $200m in a Europe-focused venture capital fund formed by Mubadala, which had committed $15bn to its Vision Fund two years ago.
Feb 19, 2019Straub gets the rub at Bioventure
Siemens Technology Accelerator venture director Nico Straub has taken a partner position at Bioventure Consulting after nearly six years at the unit.
Feb 14, 2019MML seeks corporate commitments for second fund
The Irish private equity investor is reportedly approaching AIG, Goldpoint and Cigna, all of which backed the firm's debut vehicle in 2013, for commitments to its Fund II.
Feb 14, 2019Armilar accepts Semapa and KNP for fifth fund
The corporate venturing units of Semapa and KPN have contributed to Armilar's TechTransfer Fund, which has raised almost $51m on its way to a target of about $68m.
Feb 13, 2019HiberCell absorbs series A funding
The metastatic cancer drug developer has secured $60.8m from investors including Celgene and the WuXi AppTec-backed 6 Dimensions Capital.
Feb 11, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


